Affiliation:
1. Department of Advanced Green Energy and Environment, Handong Global University, Pohang, Gyungbuk, South Korea
2. Beneficial Microbes Center, CJ Foods R&D, CJ CheilJedang Corporation, Suwon, Gyeonggi, South Korea
Abstract
BackgroundOverweight and abdominal obesity, in addition to medical conditions such as high blood pressure, high blood sugar and triglyceride levels, are typical risk factors associated with metabolic syndrome. Yet, considering the complexity of factors and underlying mechanisms leading to these inflammatory conditions, a deeper understanding of this area is still lacking. Some probiotics have a reputation of a relatively-long history of safe use, and an increasing number of studies are confirming benefits including anti-obesity effects when administered in adequate amounts. Recent reports demonstrate that probiotic functions may widely differ with reference to either intra-species or inter-species related data. Such differences do not necessarily reflect or explain strain-specific functions of a probiotic, and thus require further assessment at the intra-species level. Various anti-obesity clinical trials with probiotics have shown discrepant results and require additional consolidated studies in order to clarify the correct dose of application for reliable and constant efficacy over a long period.MethodsThree different strains ofLactobacillus sakeiwere administered in a high-fat diet induced obese murine model using three different doses, 1 × 1010, 1 × 109and 1 × 108CFUs, respectively, per day. Changes in body and organ weight were monitored, and serum chemistry analysis was performed for monitoring obesity associated biomarkers.ResultsOnly one strain ofL. sakei(CJLS03) induced a dose-dependent anti-obesity effect, while no correlation with either dose or body or adipose tissue weight loss could be detected for the other twoL. sakeistrains (L338 and L446). The body weight reduction primarily correlated with adipose tissue and obesity-associated serum biomarkers such as triglycerides and aspartate transaminase.DiscussionThis study shows intraspecies diversity ofL. sakeiand suggests that anti-obesity effects of probiotics may vary in a strain- and dose-specific manner.
Funder
Bio and Medical Technology Development Program of the National Research Foundation
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Reference81 articles.
1. Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis;Ahmadi;Caspian Journal of Internal Medicine,2015
2. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota;Alard;Environmental Microbiology,2016
3. Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties;Alemka;Infection and Immunity,2010
4. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial;Aller;European Review for Medical and Pharmacological Sciences,2011
5. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers;Al-muzafar;BMC Complementary and Alternative Medicine,2017
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献